BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 31097290)

  • 1. Challenges in the Pap diagnosis of endocervical adenocarcinoma in situ.
    Niu S; Molberg K; Thibodeaux J; Rivera-Colon G; Hinson S; Zheng W; Lucas E
    J Am Soc Cytopathol; 2019; 8(3):141-148. PubMed ID: 31097290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocervical adenocarcinoma in situ-from Papanicolaou test to hysterectomy: a series of 74 cases.
    Lashmanova N; Braun A; Cheng L; Gattuso P; Yan L
    J Am Soc Cytopathol; 2022; 11(1):13-20. PubMed ID: 34509373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
    Harbhajanka A; Dahoud W; Michael CW
    Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-negative Papanicolaou tests in women with biopsy-proven invasive endocervical adenocarcinoma/adenocarcinoma in situ: a retrospective analysis with assessment of interobserver agreement.
    Lin M; Narkcham S; Jones A; Armylagos D; DiPietro B; Okafor O; Tracey P; Vercher T; Vasquez S; Haley S; Crumley S; Gorman B; Jacobi E; Amrikachi M; Coffey D; Mody D; Okoye E
    J Am Soc Cytopathol; 2022; 11(1):3-12. PubMed ID: 34583894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glandular epithelial abnormalities on thinprep® pap tests: Clinical and cytohistologic correlation.
    Selvaggi SM
    Diagn Cytopathol; 2016 May; 44(5):389-93. PubMed ID: 26878832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Patadji S; Li Z; Pradhan D; Zhao C
    Cancer Cytopathol; 2017 Mar; 125(3):205-211. PubMed ID: 28060456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of the Pap smear for glandular lesions of the cervix and endometrium.
    Geldenhuys L; Murray ML
    Acta Cytol; 2007; 51(1):47-50. PubMed ID: 17328495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.
    Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC
    Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C; Li Z; Austin RM
    Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
    Pulkkinen J; Huhtala H; Krogerus LA; Hollmén S; Laurila M; Kholová I
    Acta Cytol; 2022; 66(3):206-215. PubMed ID: 35226896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The newly proposed International Endocervical Adenocarcinoma Criteria and Classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases.
    Ondič O; Němcová J; Alaghehbandan R; Černá K; Gomolčáková B; Kinkorová-Luňáčková I; Chytra J; Šidlová H; Hósová M; Bouda J
    Cytopathology; 2020 Jul; 31(4):288-291. PubMed ID: 32289186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reporting rates of atypical glandular cells and their HPV testing and histologic follow-up results: a comparison between ThinPrep and SurePath preparations from a single academic institution.
    Liu S; Gibbons-Fideler IS; Tonkovich D; Shen R; Li Z
    J Am Soc Cytopathol; 2019; 8(3):128-132. PubMed ID: 31097288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fortuitous detection of endocervical adenocarcinoma in situ: a report of 2 cases.
    Gurney EP; Blank SV
    J Reprod Med; 2009 Jul; 54(7):451-3. PubMed ID: 19691263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can adenocarcinoma in situ of the uterine cervix be predicted before cervical conization?
    Kietpeerakool C; Srisomboon J; Prompittayarat W; Kanjanavaha P; Peuwsai R; Dheerakul C
    Asian Pac J Cancer Prev; 2006; 7(4):522-4. PubMed ID: 17250421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
    Zhao C; Li Z; Nayar R; Levi AW; Winkler BA; Moriarty AT; Barkan GA; Rao J; Miller F; Fan F; Zhou Z; Si Q; Fischer AH; Sturgis CD; Jing X; Marshall CB; Witt BL; Birdsong GG; Crothers BA
    Arch Pathol Lab Med; 2015 Feb; 139(2):184-8. PubMed ID: 24694342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.